Med spa & injectable regulations by state
Pick your state to see the GLP-1 compounding, scope-of-practice, and enforcement changes we’re tracking there — plus the federal FDA and Federal Register actions that apply everywhere. Plain-language alerts and what to do.
Want every state on one page? The at-a-glance grid puts each jurisdiction beside the four questions buyers ask most, each cell a judged citation.
- Alabama1 alert
- Alaskamonitoring
- Arizona1 alert
- Arkansasmonitoring
- California1 alert
- Colorado2 alerts
- Connecticutmonitoring
- Delawaremonitoring
- District of Columbiamonitoring
- Florida1 alert
- Georgia2 alerts
- Hawaii1 alert
- Idahomonitoring
- Illinois2 alerts
- Indiana1 alert
- Iowa1 alert
- Kansasmonitoring
- Kentucky1 alert
- Louisianamonitoring
- Maine1 alert
- Marylandmonitoring
- Massachusetts1 alert
- Michiganmonitoring
- Minnesotamonitoring
- Mississippi1 alert
- Missourimonitoring
- Montanamonitoring
- Nebraskamonitoring
- Nevadamonitoring
- New Hampshiremonitoring
- New Jerseymonitoring
- New Mexicomonitoring
- New Yorkmonitoring
- North Carolina1 alert
- North Dakotamonitoring
- Ohio2 alerts
- Oklahoma1 alert
- Oregonmonitoring
- Pennsylvania1 alert
- Rhode Island3 alerts
- South Carolina2 alerts
- South Dakotamonitoring
- Tennessee2 alerts
- Texas3 alerts
- Utahmonitoring
- Vermontmonitoring
- Virginiamonitoring
- Washington2 alerts
- West Virginia2 alerts
- Wisconsin7 alerts
- Wyomingmonitoring
Get changes for your state — free
The weekly Brief covers what changed across your states, the FDA, and the Federal Register. Members get a specific what-to-do wherever a change calls for one, in one daily email.
Get the free Brief →Regulatory monitoring, not legal advice.
Get regulatory changes as they publish
We scan all 50 state legislatures daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address